Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
Open Access
- 10 July 2019
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 23 (1) , 1-10
Abstract
To compare the efficacy of systemic treatment with linezolid (LNZ) versus vancomycin (VAN) on methicillin-resistant Staphylococcus aureus (MRSA) burden and eradication in endotracheal tube (ETT) biofilm and ETT cuff from orotracheally intubated patients with MRSA respiratory infection. Prospective observational clinical study was carried out at four European tertiary hospitals. Plasma and endotracheal aspirate (ETA) levels of LNZ and VAN were determined 72 h after treatment initiation through high-performance liquid chromatography or bioassay. LNZ or VAN concentration in the ETT biofilm and MRSA burden and eradication was determined upon extubation. The minimum inhibitory concentration (MIC) for LNZ and VAN was assessed by E-test strips (Biomerieux®). Scanning electron microscopy images were obtained, and ETT biofilm thickness was compared between groups. Twenty-five patients, 15 treated with LNZ and 10 with VAN, were included in the study. LNZ presented a significantly higher concentration (μg/mL) than VAN in ETT biofilm (72.8 [1.3–127.1] vs 0.4 [0.4–1.3], p < 0.001), although both drugs achieved therapeutic plasma levels 72 h after treatment initiation. Systemic treatment with LNZ achieved lower ETT cuff MRSA burdens than systemic treatment with VAN. Indeed, LNZ increased the MRSA eradication rate in ETT cuff compared with VAN (LNZ 75%, VAN 20%, p = 0.031). In ICU patients with MRSA respiratory infection intubated for long periods, systemic treatment with LNZ obtains a greater beneficial effect than VAN in limiting MRSA burden in ETT cuff.Keywords
Funding Information
- CIBER de enfermedades respiratorias- Ciberes (CB 06/06/0028)
- Pfizer (WI173058)
- Pfizer (ASPIRE award 2011)
- Institució Catalana de Recerca i Estudis Avançats (ICREA Academy)
- IDIBAPS (2.603)
- Generalitat de Catalunya (SGR)
This publication has 30 references indexed in Scilit:
- Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubesCritical Care Medicine, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled StudyClinical Infectious Diseases, 2012
- A clinical assessment of the Mucus ShaverCritical Care Medicine, 2012
- Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs*Critical Care Medicine, 2012
- Nosocomial tracheobronchitisCurrent Opinion in Infectious Diseases, 2009
- Automatic control of tracheal tube cuff pressure in ventilated patients in semirecumbent position: A randomized trial*Critical Care Medicine, 2007
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993